Author: heikeworthington
Canada – Patented Medicine Prices Review Board Imposes Deadline for Motions for Leave to Intervene in the Redetermination of Board Decisions Regarding the Excessive Pricing of Soliris Dated September 27 and November 8, 2017
The Patented Medicine Prices Review Board will hold a public rehearing in the matter of the price of the patented medicine Soliris, and Alexion Pharmaceuticals Inc., the pharmaceutical company that holds the patent for Soliris and sells the medicine in Canada. April 1, 2022 – Ottawa, ON – Patented Medicine Prices Review Board The Patented Medicine Prices Review Board will hold a public rehearing in the matter of the price of the patented medicine Soliris, and Alexion Pharmaceuticals Inc., the pharmaceutical company that holds the patent for Soliris and sells the medicine in Canada. Further details on the public rehearing ... Read more